Two Sigma Investments
BRTX icon

Two Sigma Investments’s BioRestorative Therapies BRTX Stock Holding History

Two Sigma Investments’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,167
Closed -$25.1K – 3046
2024
Q1 		$25.1K Buy
+18,167
New +$28K ﹤0.01% 2921
2023
Q2 		– Sell
-17,026
Closed -$57.9K – 3025
2023
Q1 		$57.9K Buy
+17,026
New +$52.2K ﹤0.01% 2733

Other funds holding BRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UFA
US Financial Advisors Braintree, Massachusetts $338M AUM 4.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Two Sigma Investments's BRTX Position: Q2 2024 in Review

Two Sigma Investments sold out of BioRestorative Therapies (BRTX) in Q2 2024, closing a stake of 18,167 shares — an estimated $25.1K sold.

Two Sigma Investments first reported a position in BRTX in Q1 2023 and held it in 2 quarters. The position peaked at $57.9K in Q1 2023. 12 funds tracked by Wall St. Rank hold BRTX as of Q2 2024.

  • Two Sigma Investments reported no remaining BioRestorative Therapies position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 18,167 BioRestorative Therapies shares in Q2 2024, an estimated $25.1K.
  • Two Sigma Investments first reported a position in BioRestorative Therapies in Q1 2023 and held it in 2 quarters.
  • Two Sigma Investments's BioRestorative Therapies position peaked at $57.9K in Q1 2023.
  • 12 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.